Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Expanded breadth of the T-cell response to mosaic HIV-1 envelope DNA vaccination

Journal Article · · Journal of Virology

An effective AIDS vaccine must control highly diverse circulating strains of HIV-1. Among HIV -I gene products, the envelope (Env) protein contains variable as well as conserved regions. In this report, an informatic approach to the design of T-cell vaccines directed to HIV -I Env M group global sequences was tested. Synthetic Env antigens were designed to express mosaics that maximize the inclusion of common potential Tcell epitope (PTE) 9-mers and minimize the inclusion of rare epitopes likely to elicit strain-specific responses. DNA vaccines were evaluated using intracellular cytokine staining (ICS) in inbred mice with a standardized panel of highly conserved 15-mer PTE peptides. I, 2 and 3 mosaic sets were developed that increased theoretical epitope coverage. The breadth and magnitude ofT-cell immunity stimulated by these vaccines were compared to natural strain Env's; additional comparisons were performed on mutant Env's, including gpl60 or gpl45 with or without V regions and gp41 deletions. Among them, the 2 or 3 mosaic Env sets elicited the optimal CD4 and CD8 responses. These responses were most evident in CD8 T cells; the 3 mosaic set elicited responses to an average of 8 peptide pools compared to 2 pools for a set of3 natural Env's. Synthetic mosaic HIV -I antigens can therefore induce T-cell responses with expanded breadth and may facilitate the development of effective T -cell-based HIV -1 vaccines.

Research Organization:
Los Alamos National Laboratory (LANL)
Sponsoring Organization:
DOE
DOE Contract Number:
AC52-06NA25396
OSTI ID:
956488
Report Number(s):
LA-UR-09-00148; LA-UR-09-148
Journal Information:
Journal of Virology, Journal Name: Journal of Virology; ISSN JOVIAM; ISSN 0022-538X
Country of Publication:
United States
Language:
English

References (101)

Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design journal May 2008
Cross‐Clade Detection of HIV‐1–Specific Cytotoxic T Lymphocytes Does Not Reflect Cross‐Clade Antiviral Activity journal February 2008
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1 journal August 2007
Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys journal November 2008
A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans journal April 2004
Increased detection of HIV-specific T cell responses by combination of central sequences with comparable immunogenicity journal January 2008
Vaccination to prevent persistent viral infection journal July 1993
Evidence of Differential HLA Class I-Mediated Viral Evolution in Functional and Accessory/Regulatory Genes of HIV-1 journal July 2007
Higher HIV-1 Incidence and Genetic Complexity Along Main Roads in Rakai District, Uganda journal December 2006
Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines journal September 2001
Design, Construction, and Characterization of a Multigenic Modified Vaccinia Ankara Candidate Vaccine Against Human Immunodeficiency Virus Type 1 Subtype C/B′ journal April 2008
Protection by Live, Attenuated Simian Immunodeficiency Virus against Heterologous Challenge journal October 1999
A Simple, Fast, and Accurate Algorithm to Estimate Large Phylogenies by Maximum Likelihood journal October 2003
Partial Protection of Simian Immunodeficiency Virus (SIV)-Infected Rhesus Monkeys against Superinfection with a Heterologous SIV Isolate journal March 2009
Multiclade Human Immunodeficiency Virus Type 1 Envelope Immunogens Elicit Broad Cellular and Humoral Immunity in Rhesus Monkeys journal February 2005
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine journal May 2007
Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin journal July 2004
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection journal May 2008
Marked Epitope- and Allele-Specific Differences in Rates of Mutation in Human Immunodeficiency Type 1 (HIV-1) Gag, Pol, and Nef Cytotoxic T-Lymphocyte Epitopes in Acute/Early HIV-1 Infection journal July 2008
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis journal November 2008
Cross-subtype antibody and cellular immune responses induced by a polyvalent DNA prime–protein boost HIV-1 vaccine in healthy human volunteers journal July 2008
Antiviral pressure exerted by HIV-l-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus journal February 1997
A group M consensus envelope glycoprotein induces antibodies that neutralize subsets of subtype B and C HIV-1 primary viruses journal September 2006
A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques journal January 2002
A Sound Rationale Needed for Phase III HIV-1 Vaccine Trials journal January 2004
Crippling HIV one mutation at a time journal May 2008
Efficacy of pneumococcal vaccination in adults: a meta-analysis journal January 2009
Protective HLA Class I Alleles That Restrict Acute-Phase CD8+ T-Cell Responses Are Associated with Viral Escape Mutations Located in Highly Conserved Regions of Human Immunodeficiency Virus Type 1 journal November 2008
Safety and immunogenicity of cytotoxic T-lymphocyte poly-epitope, DNA plasmid (EP HIV-1090) vaccine in healthy, human immunodeficiency virus type 1 (HIV-1)-uninfected adults journal January 2008
Characterization of Complete HIV Type 1 Genomes from Non-B Subtype Infections in U.S. Military Personnel journal May 2005
Vaccination against hepatitis A and B: developments, deployment and delusions journal October 2006
HLA and HIV-1: Heterozygote Advantage and B*35 - Cw*04 Disadvantage journal March 1999
Effect of Human Immunodeficiency Virus Type 1 (HIV‐1) Subtype on Disease Progression in Persons from Rakai, Uganda, with Incident HIV‐1 Infection journal March 2008
Live attenuated simian immunodeficiency virus (SIV)mac in macaques can induce protection against mucosal infection with SIVsm journal January 1998
Limitations of a Molecular Clock Applied to Considerations of the Origin of HIV-1 journal June 1998
Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation journal November 2006
Founder Effects in the Assessment of HIV Polymorphisms and HLA Allele Associations journal March 2007
Post-Step modifications for research on HIV vaccines journal January 2009
HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors journal February 2000
Diversity Considerations in HIV-1 Vaccine Selection journal June 2002
Reconstruction and Function of Ancestral Center-of-Tree Human Immunodeficiency Virus Type 1 Proteins journal August 2007
Superior control of HIV-1 replication by CD8+ T cells is reflected by their avidity, polyfunctionality, and clonal turnover journal September 2007
Advantage of rare HLA supertype in HIV disease progression journal June 2003
Timing the Ancestor of the HIV-1 Pandemic Strains journal June 2000
HIV vaccine development by computer assisted design: the GAIA vaccine journal March 2005
Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques journal March 2005
Modifications of the Human Immunodeficiency Virus Envelope Glycoprotein Enhance Immunogenicity for Genetic Immunization journal June 2002
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants journal December 2006
Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins journal March 2007
Cross-Subtype T-Cell Immune Responses Induced by a Human Immunodeficiency Virus Type 1 Group M Consensus Env Immunogen journal June 2006
Direct evidence of extensive diversity of HIV-1 in Kinshasa by 1960 journal October 2008
Construction, Characterization, and Immunogenicity of a Multigene Modified Vaccinia Ankara (MVA) Vaccine Based on HIV Type 1 Subtype C journal February 2008
Viral load differences in early infection with two HIV-1 subtypes journal January 2001
Immunological and Virological Analyses of Persons Infected by Human Immunodeficiency Virus Type 1 while Participating in Trials of Recombinant gp120 Subunit Vaccines journal February 1998
HIV CTL escape: at what cost? journal January 2004
Expanded Breadth of the T-Cell Response to Mosaic Human Immunodeficiency Virus Type 1 Envelope DNA Vaccination journal December 2008
Correlation between Immunologic Responses to a Recombinant Glycoprotein 120 Vaccine and Incidence of HIV‐1 Infection in a Phase 3 HIV‐1 Preventive Vaccine Trial journal March 2005
Induction of a Striking Systemic Cytokine Cascade prior to Peak Viremia in Acute Human Immunodeficiency Virus Type 1 Infection, in Contrast to More Modest and Delayed Responses in Acute Hepatitis B and C Virus Infections journal January 2009
A "string-of-beads" vaccine, comprising linked minigenes, confers protection from lethal-dose virus challenge journal January 1993
HIV-1 Group M Conserved Elements Vaccine journal January 2007
Induction of Multifunctional Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T Cells Capable of Proliferation in Healthy Subjects by Using a Prime-Boost Regimen of DNA- and Modified Vaccinia Virus Ankara-Vectored Vaccines Expressing HIV-1 Gag Coupled to CD8+ T-Cell Epitopes journal May 2006
Influence of combinations of human major histocompatibility complex genes on the course of HIV–1 infection journal April 1996
Multifunctional T-Cell Characteristics Induced by a Polyvalent DNA Prime/Protein Boost Human Immunodeficiency Virus Type 1 Vaccine Regimen Given to Healthy Adults Are Dependent on the Route and Dose of Administration journal July 2008
Development of a DNA Vaccine Designed to Induce Cytotoxic T Lymphocyte Responses to Multiple Conserved Epitopes in HIV-1 journal November 2003
Retracing our STEP towards a successful CTL-based HIV-1 vaccine journal June 2008
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine journal October 2007
Profiling the Specificity of Neutralizing Antibodies in a Large Panel of Plasmas from Patients Chronically Infected with Human Immunodeficiency Virus Type 1 Subtypes B and C journal September 2008
Coping with Viral Diversity in HIV Vaccine Design journal April 2007
Recognition of Escape Variants in ELISPOT Does Not Always Predict CD8+ T-Cell Recognition of Simian Immunodeficiency Virus-Infected Cells Expressing the Same Variant Sequences journal October 2007
Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial journal February 2006
Design and construction of an experimental HIV-1 vaccine for a year-2000 clinical trial in Kenya. journal September 2000
HLA Class I-Driven Evolution of Human Immunodeficiency Virus Type 1 Subtype C Proteome: Immune Escape and Viral Load journal July 2008
Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution
  • Yusim, Karina; Peeters, Martine; Pybus, Oliver G.
  • Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences, Vol. 356, Issue 1410 https://doi.org/10.1098/rstb.2001.0859
journal June 2001
Highly complex neutralization determinants on a monophyletic lineage of newly transmitted subtype C HIV-1 Env clones from India journal March 2009
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia journal October 2008
Antigenicity and Immunogenicity of a Synthetic Human Immunodeficiency Virus Type 1 Group M Consensus Envelope Glycoprotein journal December 2004
Web-based design and evaluation of T-cell vaccine candidates journal May 2008
Evidence for Heterogeneous Selective Pressures in the Evolution of the env Gene in Different Human Immunodeficiency Virus Type 1 Subtypes journal February 2005
Subtype-specific Transmission Probabilities for Human Immunodeficiency Virus Type 1 among Injecting Drug Users in Bangkok, Thailand journal January 2002
HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells journal June 2006
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection journal January 2003
Consensus and Ancestral State HIV Vaccines journal March 2003
Clustering Patterns of Cytotoxic T-Lymphocyte Epitopes in Human Immunodeficiency Virus Type 1 (HIV-1) Proteins Reveal Imprints of Immune Evasion on HIV-1 Global Variation journal September 2002
Safety and immunogenicity of recombinant low-dosage HIV-1 A vaccine candidates vectored by plasmid pTHr DNA or modified vaccinia virus Ankara (MVA) in humans in East Africa journal May 2008
Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load journal February 2003
HLA-B57/B*5801 Human Immunodeficiency Virus Type 1 Elite Controllers Select for Rare Gag Variants Associated with Reduced Viral Replication Capacity and Strong Cytotoxic T-Lymphotye Recognition journal December 2008
Comprehensive Cross-Clade Neutralization Analysis of a Panel of Anti-Human Immunodeficiency Virus Type 1 Monoclonal Antibodies journal December 2004
Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2 journal February 2007
Adaptation of HIV-1 to human leukocyte antigen class I journal February 2009
Human Immunodeficiency Virus Type 1 Subtype B Ancestral Envelope Protein Is Functional and Elicits Neutralizing Antibodies in Rabbits Similar to Those Elicited by a Circulating Subtype B Envelope journal August 2005
A centralized gene-based HIV-1 vaccine elicits broad cross-clade cellular immune responses in rhesus monkeys journal July 2008
Component‐Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a Sentinel Surveillance Network in Canada, 2006–2007 journal January 2009
Modifying the HIV-1 env gp160 gene to improve pDNA vaccine-elicited cell-mediated immune responses journal September 2008
Clade-Specific Differences between Human Immunodeficiency Virus Type 1 Clades B and C: Diversity and Correlations in C3-V4 Regions of gp120 journal May 2007
Coping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al. journal January 2008
HIV-1 Nomenclature Proposal journal April 2000
Macaques vaccinated with live-attenuated SIV control replication of heterologous virus journal October 2008
Estimating selection pressures on HIV-1 using phylogenetic likelihood models journal October 2008
Consistent Cytotoxic-T-Lymphocyte Targeting of Immunodominant Regions in Human Immunodeficiency Virus across Multiple Ethnicities journal February 2004
Genetic Characterization of Diverse HIV-1 Strains in an Immigrant Population Living in New York City journal April 2006
Ancestral and consensus envelope immunogens for HIV-1 subtype C journal September 2006

Similar Records

Trivalent mosaic or consensus HIV immunogens prime humoral and broader cellular immune responses in adults
Journal Article · Tue Feb 14 23:00:00 EST 2023 · Journal of Clinical Investigation · OSTI ID:2470542

Inability to induce consistent T-cell responses recognizing conserved regions within HIIV-1 antigens: a potential mechanism for lack of vaccine efficacy in the step study
Journal Article · Wed Dec 31 23:00:00 EST 2008 · Journal of Infectious Diseases · OSTI ID:970582

Comparison of the depth of vaccine-elicited HIV-1 Env epitope-specific CD8+ T lymphocyte responses
Journal Article · Thu Sep 13 00:00:00 EDT 2012 · Retrovirology · OSTI ID:1629286